# Amphastar Pharmaceuticals, Inc.: Form 8-K, filed Apr 24, 2023

- Company: [Amphastar Pharmaceuticals, Inc.](/companies/amph.md) (CIK 1297184)
- Form: 8-K
- Filed: 2023-04-24
- Accepted by EDGAR: Apr 24, 2023, 07:17 ET
- Period: 2023-04-21
- Accession: 0001558370-23-006469
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1297184/000155837023006469/amph-20230421x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1297184/000155837023006469/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1297184/000155837023006469/amph-20230421x8k.htm

Filed Apr 24, 2023.
Source: SEC EDGAR, the filing index for accession 0001558370-23-006469. Last ingested by Listed: Nov 4, 2026, 17:05 ET. No prices; not investment advice.